Digital Biopharma Operations Need Better PAT and Staff Training

Digital Biopharma Operations Need Better PAT and Staff Training

 

Traditionally, the drug industry has been reluctant to try new processes. The prevailing wisdom is that strict product quality rules and the complexity of modifying approved processes have made firms reluctant to innovate.

But biopharma is finally warming to the idea of digitized manufacturing, according to Duygu Dikicioglu, PhD, associate professor at University College London’s (UCL) department of biochemical engineering.

Read the article here:
www.genengnews.com/topics/bioprocessing/digital-biopharma-operations-needs-better-pat-and-staff-training/